Acciones Neurokine Pharmaceuticals Inc Other OTC
Acciones
CAC611561100
Biotecnología e investigación médica
Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
Ventas 2022 | - | Ventas 2023 | - | Capitalización | 13,32 M 12,48 M |
---|---|---|---|---|---|
Resultado Neto 2022 | -12 M -11,25 M | Resultado Neto 2023 | -9 M -8,44 M | VE / Ventas 2022 | - |
Deuda neta 2022 | 139 mil 130 mil | Deuda neta 2023 | 71,69 mil 67,22 mil | VE / Ventas 2023 | - |
P/E ratio 2022 |
-1,26
x | P/E ratio 2023 |
-1,36
x | Empleados | - |
Rendimiento 2022 * |
-
| Rendimiento 2023 |
-
| Flotante | 77,36 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17/09/07 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 26/12/10 |
Chief Operating Officer | 67 | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17/09/07 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 21/01/20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05/02/15 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-3,46 % | 102 mil M | |
+1,41 % | 96,29 mil M | |
+2,13 % | 22,18 mil M | |
-15,84 % | 21,2 mil M | |
-9,21 % | 18,31 mil M | |
-39,98 % | 17,38 mil M | |
-14,65 % | 16,36 mil M | |
+4,39 % | 13,97 mil M | |
+31,35 % | 12,17 mil M |